Biotechnology Innovation Organization: New Ruling Out of Texas Sets "Dangerous Precedent for Undermining the FDA"
April 08, 2023
April 08, 2023
WASHINGTON, April 8 (TNStalk) -- The Biotechnology Innovation Organization issued the following statement:
* * *
A federal judge in Texas rules this week to suspend the FDA's approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement.
"The preliminary ruling by a federal judge in Texas is an assault on science and the FDA's long-standing role as the authority to make decisions on the safety and efficacy of me . . .
* * *
A federal judge in Texas rules this week to suspend the FDA's approval of mifepristone. BIO interim President and CEO, Rachel King, released the following statement.
"The preliminary ruling by a federal judge in Texas is an assault on science and the FDA's long-standing role as the authority to make decisions on the safety and efficacy of me . . .